Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $117.1800 (-7.53%) ($112.2700 - $127.7000) on Fri. Jul. 31, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.11% (three month average) | RSI | 58 | Latest Price | $117.1800(-7.53%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -0.4% a day on average for past five trading days. | Weekly Trend | LGND advances 1.5% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(54%) IWO(52%) XBI(50%) IWC(47%) IWM(47%) | Factors Impacting LGND price | LGND will decline at least -1.555% in a week (0% probabilities). VIXM(-22%) UUP(-16%) VXX(-15%) IYT(-4%) UNG(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.555% (StdDev 3.11%) | Hourly BBV | 0 () | Intraday Trend | -7.9% | | | |
|
Resistance Level | $119.53 | 5 Day Moving Average | $123(-4.73%) | 10 Day Moving Average | $122.74(-4.53%) | 20 Day Moving Average | $119.53(-1.97%) | To recent high | -7.5% | To recent low | 26% | Market Cap | $1.883b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |